| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/11/1996 | WO1995031559A3 Methods of inducing gene expression by ionizing radiation |
| 01/11/1996 | WO1995030001A3 Novel p-selectin ligand protein |
| 01/11/1996 | WO1995028486A3 Recombinant proteins of filamentous haemagglutinin of bordetella, particularly bordetella pertussis, method for producing same, and uses thereof for producing foreign proteins or vaccinating active principles |
| 01/11/1996 | DE4423392A1 Verfahren zur Identifizierung antigener Peptide A method for identifying antigenic peptides |
| 01/11/1996 | DE4422238A1 Verfahren zur Isolierung einer Antigenpräparation A method for isolating an antigenic preparation |
| 01/11/1996 | DE19515310A1 Artificial hip ball joint |
| 01/11/1996 | CA2193997A1 Nucleic acid fragments and corresponding peptide fragments from the caprine arthritis-encephalitis virus (caev) genome, and uses thereof |
| 01/11/1996 | CA2193859A1 Antibodies which bind to insect gut proteins and their use |
| 01/11/1996 | CA2193828A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 01/11/1996 | CA2193809A1 Modified g-protein coupled receptors |
| 01/11/1996 | CA2193802A1 Aav capsid vehicles for molecular transfer |
| 01/11/1996 | CA2193090A1 Bacillus thuringiensis isolates active against cockroaches |
| 01/11/1996 | CA2192957A1 Semenogelin-derived oligopeptides cleavable by prostate specific antigen |
| 01/11/1996 | CA2190756A1 Endothelin antagonists ii |
| 01/11/1996 | CA2190642A1 Agents affecting thrombosis and hemostasis |
| 01/10/1996 | EP0691406A1 Process for the preparation of superoxide dismutase by recombinant DNA-technology |
| 01/10/1996 | EP0691404A2 Improved vaccines for the immunisation against TBE-Virusinfections and method for their preparation |
| 01/10/1996 | EP0691403A1 Family of primate IP-3-like hemapoietic growth factors |
| 01/10/1996 | EP0691402A2 Modified satellite-RNA's and satellite-viruses as support for adapted ribozymes |
| 01/10/1996 | EP0691349A2 Dimeric bone morphogenic proteins and fragments and analogs thereof and pharmaceutical compositions comprising them |
| 01/10/1996 | EP0691348A1 Immunogenic compositions prepared from adenylate cyclase of B. Parapertussis |
| 01/10/1996 | EP0691347A1 Hepatic parenchymal cell growth substance |
| 01/10/1996 | EP0690991A1 Novel anticoagulant cofactor activity |
| 01/10/1996 | EP0690990A1 Parvovirus receptors and methods of use |
| 01/10/1996 | EP0690920A1 Biological control agents containing mollusc toxins |
| 01/10/1996 | EP0690919A1 Crucifer acc synthase and uses thereof |
| 01/10/1996 | EP0690918A1 Protein tyrosine phosphatase ptp-s31 |
| 01/10/1996 | EP0690917A1 Recombinant epstein-barr virus protein and its use in vaccine |
| 01/10/1996 | EP0690916A1 Novel pesticidal proteins and strains |
| 01/10/1996 | EP0690915A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 01/10/1996 | EP0690914A1 Allergenic protein and peptides from house dust mite and uses therefor |
| 01/10/1996 | EP0690913A1 Expression of heterologous polypeptides in halobacteria |
| 01/10/1996 | EP0690912A1 Recombinant avian adenovirus vector |
| 01/10/1996 | EP0690876A1 Protein kinases |
| 01/10/1996 | EP0690875A1 Botulinum toxin polypeptides and their use as vaccine enhancing agents |
| 01/10/1996 | EP0690874A1 Materials and methods relating to proteins that interact with casein kinase i |
| 01/10/1996 | EP0690873A1 Growth differentiation factor-8 |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690871A1 Growth differentiation factor-5 |
| 01/10/1996 | EP0690869A1 Cellular regulation with riboregulators |
| 01/10/1996 | EP0690724A1 Chlamydia vaccine and process |
| 01/10/1996 | EP0690723A1 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 01/10/1996 | EP0690720A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 01/10/1996 | EP0690675A1 Nucleic acid coding for a tumor rejection antigen precursor |
| 01/10/1996 | EP0690673A1 Systemic gene treatment of connective tissue diseases |
| 01/10/1996 | EP0637970A4 Polyamino acid superabsorbents. |
| 01/10/1996 | EP0599850B1 Composition and method for treating cystic fibrosis |
| 01/10/1996 | EP0484508B1 Proteinaceous fat substitute |
| 01/10/1996 | EP0484464B1 Method of cleansing proteins |
| 01/10/1996 | CN1114836A Displacement chromatography process and purified hemoglobin product |
| 01/09/1996 | US5482929 Aluminum salt of cyclodextrin sulfate |
| 01/09/1996 | US5482928 Biocidal proteins |
| 01/09/1996 | US5482924 Proteinaceous compositions having an activity on erythropoiesis |
| 01/09/1996 | US5482853 Nuclear sequence for cellular genomes |
| 01/09/1996 | US5482851 Nucleic acid encoding TGF-β and its uses |
| 01/09/1996 | US5482850 Method for identifying anti-parasitic compounds |
| 01/09/1996 | US5482838 Down-regulation of plasminogen activator inhibitor and beta-amyloid precursor protein |
| 01/09/1996 | US5482835 Methods of testing in yeast cells for agonists and antagonists of mammal G-protein coupled receptors |
| 01/09/1996 | US5482723 Streptococcus bacteria for milk |
| 01/09/1996 | US5482713 Equine herpesvirus recombinant poxvirus vaccine |
| 01/09/1996 | US5482709 Eimeria antigenic composition which elicits antibodies against avian coccidiosis |
| 01/09/1996 | US5482708 Leukemia, proteins are not adjacent in native protein |
| 01/05/1996 | CA2153109A1 Synthetic peptide derivatives and the salts thereof |
| 01/04/1996 | WO1996000392A1 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions |
| 01/04/1996 | WO1996000300A1 Anergy genes |
| 01/04/1996 | WO1996000299A1 Nucleic acid fragments, derivatives of the mycobacterium xenopi genome, and applications thereof |
| 01/04/1996 | WO1996000294A1 Improvements in or relating to delivery of nucleic acids |
| 01/04/1996 | WO1996000289A1 Protocadherin proteins and their uses |
| 01/04/1996 | WO1996000288A2 Class bi and ci scavenger receptors |
| 01/04/1996 | WO1996000287A1 Dna coding for caldecrin and process for producing caldecrin by using the dna |
| 01/04/1996 | WO1996000242A1 Retinoic acid receptor epsilon |
| 01/04/1996 | WO1996000241A1 Process for the preparation of peptide trisulfides |
| 01/04/1996 | WO1996000240A1 Novel protein and process for producing the same |
| 01/04/1996 | WO1996000239A1 Method of isolating isolectins from mistletoe |
| 01/04/1996 | WO1996000238A1 T cell epitopes of rye grass pollen allergen |
| 01/04/1996 | WO1996000237A1 Filtration |
| 01/04/1996 | WO1996000233A1 Escherichia coli o157:h7 epithelial adhesin |
| 01/04/1996 | WO1996000086A1 Therapeutic method and remedy for diabetes |
| 01/04/1996 | WO1996000083A2 Method of isolating an antigene preparation |
| 01/04/1996 | WO1996000080A1 Non-antigenic amine derived polymers and polymer conjugates |
| 01/04/1996 | WO1996000007A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 01/04/1996 | WO1995034649A3 Polycystic kidney disease 1 gene and uses thereof |
| 01/04/1996 | WO1995033059A3 Receptor for oncostatin m |
| 01/04/1996 | WO1995033049A3 Tbp2 fragments of the transferrine receptor of neisseria meningitidis |
| 01/04/1996 | WO1995030018A3 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 01/04/1996 | WO1995030015A3 Isolated epstein-barr virus bzlf2 proteins that bind mhc class ii beta chains |
| 01/04/1996 | WO1995029193A3 Melanoma antigens |
| 01/04/1996 | DE4423131A1 Neue hIL-4-Mutantenproteine als Antagonisten oder partielle Agonisten des humanen Interleukin 4 New hIL-4 mutant proteins as antagonists or partial agonists of human interleukin 4 |
| 01/04/1996 | DE4421895A1 Verfahren zur Isolierung von Isolektinen aus der Mistel A method for isolating Isolektinen from mistletoe |
| 01/04/1996 | DE4421742A1 Haemoglobin hyper-polymer prodn. |
| 01/04/1996 | DE19523554A1 Helicobacter pylori-Impfstoffe und therapeutische Zusammensetzungen Helicobacter pylori vaccines and therapeutic compositions |
| 01/04/1996 | DE19511243A1 Neuer Wachstums-/Differenzierungsfaktor der TGF-beta-Familie New growth / differentiation factor of the TGF-beta family |
| 01/04/1996 | CA2193860A1 T cell epitopes of rye grass pollen allergen |
| 01/04/1996 | CA2193832A1 Class bi and ci scavenger receptors |
| 01/04/1996 | CA2193812A1 Improvements in or relating to delivery of nucleic acids |
| 01/04/1996 | CA2193081A1 Method of isolating an antigene preparation |
| 01/04/1996 | CA2191726A1 Non-antigenic amine derived polymers and polymer conjugates |
| 01/04/1996 | CA2170156A1 Protocadherin proteins and their uses |
| 01/04/1996 | CA2169953A1 Basic osteoblast growth factor ii (bogf-ii) and methods for producing it |
| 01/03/1996 | EP0690307A1 Method of determining the presence of an autoimmune antibody |